Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.690
+0.030 (1.81%)
At close: Oct 2, 2025, 4:00 PM EDT
1.700
+0.010 (0.59%)
After-hours: Oct 2, 2025, 7:20 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $68.86 million as of October 2, 2025. Its market cap has decreased by -78.42% in one year.
Market Cap
68.86M
Enterprise Value
40.24M
1-Year Change
-78.42%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $68.86M, a decrease of -94.84%. That is a compound annual growth rate of -44.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 67.64M | -74.77% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.01B |
| Johnson & Johnson | 447.90B |
| AbbVie | 417.90B |
| UnitedHealth Group | 320.35B |
| AstraZeneca | 259.06B |
| Novo Nordisk | 258.32B |
| Novartis AG | 251.99B |
| Abbott Laboratories | 231.46B |